Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

PTN | Palatin Technologies Inc.

Index- P/E- EPS (ttm)-2.53 Insider Own4.79% Shs Outstand11.66M Perf Week15.13%
Market Cap20.16M Forward P/E- EPS next Y-0.48 Insider Trans0.00% Shs Float10.97M Perf Month-17.06%
Income-27.54M PEG- EPS next Q-0.41 Inst Own7.63% Short Float / Ratio4.02% / 4.74 Perf Quarter-16.67%
Sales4.85M P/S4.16 EPS this Y30.04% Inst Trans14.22% Short Interest0.44M Perf Half Y-36.13%
Book/sh0.01 P/B152.17 EPS next Y72.88% ROA-101.99% Target Price83.33 Perf Year-70.44%
Cash/sh0.95 P/C1.84 EPS next 5Y- ROE-335.84% 52W Range1.43 - 6.40 Perf YTD-31.64%
Dividend- P/FCF- EPS past 5Y- ROI-3801.97% 52W High-72.66% Beta1.01
Dividend %- Quick Ratio0.99 Sales past 5Y147.86% Gross Margin77.79% 52W Low22.38% ATR0.18
Employees34 Current Ratio1.08 Sales Q/Q128.60% Oper. Margin-689.91% RSI (14)46.54 Volatility12.15% 10.13%
OptionableYes Debt/Eq8.08 EPS Q/Q31.69% Profit Margin-567.44% Rel Volume0.58 Prev Close1.71
ShortableYes LT Debt/Eq4.54 EarningsSep 28 BMO Payout- Avg Volume93.09K Price1.75
Recom1.00 SMA20-3.98% SMA50-15.90% SMA200-32.82% Volume54,235 Change2.34%
Date Action Analyst Rating Change Price Target Change
Jun-05-15Reiterated Canaccord Genuity Buy $4 → $6
Jan-12-15Reiterated ROTH Capital Buy $6 → $4
May-23-12Initiated Noble Financial Buy
Jan-23-07Initiated Next Generation Buy $5
Today 08:35AM
Sep-29-23 01:34AM
Sep-28-23 07:30AM
Sep-22-23 04:00PM
Sep-07-23 04:00PM
07:30AM Loading…
Aug-10-23 07:30AM
Aug-08-23 07:30AM
Aug-07-23 07:30AM
Aug-04-23 07:30AM
Jul-11-23 07:30AM
May-30-23 07:30AM
May-17-23 01:39PM
May-16-23 08:45AM
07:30AM Loading…
May-15-23 09:05AM
May-11-23 05:25PM
May-09-23 05:45PM
May-08-23 04:04PM
May-01-23 04:00PM
Apr-27-23 07:30AM
Apr-25-23 07:30AM
Apr-19-23 07:30AM
Apr-18-23 07:30AM
Mar-02-23 07:30AM
Feb-28-23 07:30AM
Feb-15-23 07:30AM
07:30AM Loading…
Feb-10-23 07:30AM
Jan-26-23 05:45PM
Jan-19-23 07:30AM
Jan-18-23 07:30AM
Jan-10-23 07:30AM
Jan-05-23 07:30AM
Nov-14-22 08:55AM
Nov-10-22 08:55AM
Nov-09-22 06:45PM
Nov-08-22 07:25PM
Nov-07-22 05:15PM
Oct-31-22 09:30AM
Oct-27-22 07:05AM
Oct-24-22 05:32PM
Oct-20-22 07:30AM
Oct-17-22 07:30AM
Oct-13-22 07:30AM
Sep-29-22 03:45PM
Sep-22-22 11:00AM
Sep-19-22 04:15PM
Sep-08-22 07:30AM
Sep-02-22 10:28AM
Aug-19-22 07:30AM
Aug-16-22 07:30AM
Jul-26-22 07:30AM
Jul-13-22 10:53AM
May-17-22 08:45AM
May-16-22 07:15AM
May-12-22 08:15AM
May-11-22 09:02AM
May-10-22 08:45AM
May-09-22 05:15PM
May-05-22 06:05PM
May-02-22 01:02PM
Apr-21-22 07:30AM
Apr-13-22 08:24AM
Mar-03-22 07:30AM
Feb-15-22 07:30AM
Feb-14-22 08:15PM
Feb-10-22 05:25PM
Feb-09-22 03:01PM
Feb-08-22 02:38PM
Jan-21-22 07:30AM
Jan-07-22 10:59AM
Dec-29-21 10:18AM
Dec-28-21 07:30AM
Dec-06-21 03:55PM
Nov-30-21 07:30AM
Nov-24-21 11:20AM
Nov-15-21 07:30AM
Nov-10-21 04:30PM
Oct-22-21 07:30AM
Sep-29-21 07:30AM
Sep-27-21 07:30AM
Sep-24-21 07:30AM
Sep-15-21 07:30AM
Sep-13-21 07:00AM
Jul-22-21 05:28PM
Jul-08-21 04:15PM
Jun-29-21 07:30AM
Jun-28-21 07:30AM
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DUNTON ALAN WDirectorDec 21Sale2.9720059441,420Dec 23 05:30 PM